Novavax, Inc. (NVAX) CEO Stan Erck on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/02/21
Novavax posts wider quarterly loss, sales jump due to pandemic-related servicesMarket Watch • 03/01/21
Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational HighlightsGlobeNewsWire • 03/01/21
Novavax and Takeda Finalize License Agreement for Novavax' COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in JapanGlobeNewsWire • 02/26/21
12 Reasons Novavax Beats Pfizer For Titles Of Best Covid Vaccine And Best Covid Vaccine StockSeeking Alpha • 02/24/21
Here Are the 2 Most Important Things to Look for in Novavax's Earnings Report Next WeekThe Motley Fool • 02/24/21
Novavax completes enrollment in Phase 3 clinical trial for its COVID-19 vaccine candidateMarket Watch • 02/22/21
Novavax Achieves Target Enrollment In Pivotal Phase 3 Coronavirus Vaccine Study In US, MexicoBenzinga • 02/22/21
Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and MexicoGlobeNewsWire • 02/22/21